TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15314 · Dec 6

#python#brain_inspired_ai#deep_learning#large_language_models#reasoning The Hierarchical Reasoning Model (HRM) is a new type of AI that reasons more like a human brain, using a fast part for quick details and a slow part for big-picture planning. It solves hard logic tasks like Sudoku, mazes, and IQ-style puzzles very well, even though it is tiny (only 27 million parameters) and learns from very little data (just 1,000 examples). Unlike most large language models, it does not need long chains of written reasoning steps or huge amounts of training, which makes it much faster, cheaper, and more efficient. For the user, this means powerful reasoning in a small, fast system that can run on ordinary hardware and still beat much larger models on tough problems. https://github.com/sapientinc/HRM

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment